Brazil Bispecific Antibodies Market Size & Outlook, 2025-2031
Brazil Bispecific Antibodies Market Size
According to Straits Research analysis, the Brazil Bispecific Antibodies Market was valued at USD 55.16 Million in 2024 and is projected to reach USD 151.06 Million by 2031, expanding at a CAGR of 16.3% during the forecast period. Driven primarily by the pharmaceutical industry, bispecific antibodies are crucial in the treatment of cancers, inflammations and infectious diseases, contributing to a surge in demand. Additionally, technological advancements are catalyzing the shift towards more precise and personalized medical therapies, benefiting the market. The trend of sustainable green production and technological innovation provides new opportunities for the market. As Brazil increases its capabilities in biotechnological research and development, it is positioning itself to be a future hub for the production and export of bispecific antibodies.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Bispecific Antibodies Market Highlights
- By 2024, Bi-specific T-cell engager represented the largest share of the Type market size.
- Bi-specific T-cell engager is expected to remain the key growth driver within Type, registering the fastest CAGR during the forecast period.
- As of 2024, Brazil held 1% of the global bispecific antibodies market size.
- By 2031, United States is anticipated to capture the largest share of the global bispecific antibodies market.
- In Latin America, Rest of Latin America is expected to lead the regional bispecific antibodies market size by 2031.
- Mexico will remain the fastest-growing market in Latin America, reaching USD 46.97 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 55.16 Million |
| Market Size In 2031 | USD 151.06 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 16.3% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Brazil Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
Brazil Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Brazil Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
